Clinical TrialsSearch results
Number of results: 2443
Other
- A Phase 1, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of MEDI5752 in Japanese Subjects with Advanced Solid Tumors
- Advanced Solid Tumors
- Hibi Kazushige
- 2022-11-28
Other
- A phase 1b study of S-151128 in participants with knee osteoarthritis
- patients with knee osteoarthritis
- Juan Carlos Gomez
- 2023-11-19
Other
- A phase 2 multicenter clinical study evaluating the safety and efficacy of Nilotinib in patients with Imatinib- resistant/intolerant CML in chronic phase
- Chronic myelogenous leukemia
- Tokyo STI Study Group
- 2009-05-01
Other
- A phase 2 multicenter study evaluating the safety and efficacy of Nilotinib in patients with Imatinib-resistant/intolerant Ph+CML in chronic phase
- Chronic myelogenous leukemia
- Shimousa Hematology Study Group
- 2009-06-01
Other
- A phase 2 neoadjuvant chemotherapy of Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage 1b2 or 2 cervical cancer of the uterine cervix
- stage 1b2/2 cervical cancer
- Japanese Gynecologic Oncology Group
- 2006-12-21
Other
- A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations
- Glioblastoma, Adult-type Diffuse Gliomas
- Ueda Eiji
- 2022-09-28
Other
- A phase 2, randomized, placebo-controlled, double-blind, dose-finding study of TS-172 in hyperphosphatemia patients on hemodialysis
- Hyperphosphatemia
- Mita Seiji
- 2023-01-22
Other
- A Phase 2/3 Study of S-268019 in Adults over 60 years of ages(COVID-19)
- Prevention of COVID-19
- Nagata Tsutae
- 2022-07-26
Other
- A Phase 2/3 Study of S-268019 in Participants Aged 12 to 19 Years(COVID-19)
- Prevention of COVID-19
- Nagata Tsutae
- 2022-05-17
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Metformin
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01